Information Provided By: 
Fly News Breaks for September 23, 2019
SYNH
Sep 23, 2019 | 08:31 EDT
Jefferies analyst David Windley raised his price target for Syneos Health to $65 from $62 after meeting with management and keeps a Buy rating on the shares. Clinical revenue growth acceleration in Q2 was the primary catalyst for the stock, and management is on track to achieve the merger cost synergies, Windley tells investors in a research note.
News For SYNH From the Last 2 Days
There are no results for your query SYNH
